Mode
Text Size
Log in / Sign up
N/A N=30 Randomized Treatment

A Positive Psychology Intervention for Patients With Multiple Sclerosis

Multiple Sclerosis

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Aug 2021
Primary outcome: Primary: Percentage of PP Exercises Completed by Subjects — 93; 93 percentage of exercises completed

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Positive Psychology (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Brigham and Women's Hospital
Primary completion
Apr 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of PP Exercises Completed by Subjects
93; 93
SECONDARY
Subject Ratings of Ease of Completion of PP Exercises
9.0; 8.4; 8.1; 7.5; 7.8; 7.6
SECONDARY
Changes in Affect
4.9; -3.2; -2.6; -0.3
SECONDARY
Change in Trait Optimism
2.1; -1.3
SECONDARY
Change in Depression
-2.1; 0
SECONDARY
Change in Anxiety
-3.2; 3.4; -3.3; 2.7
SECONDARY
Changes in Health-related Quality of Life
-1.0; 0.3; 4.2; 1.1; 0.1; -0.2
SECONDARY
Change in Work Productivity
-1.0; -1.9; 1.2; 3.3; 0.1; 0.5
SECONDARY
Change in Perceived Stress
-0.4; -1.1
SECONDARY
Change in Resilience
0.1; -0.3

Summary

Positive psychology (PP) uses targeted activities to increase the frequency and intensity of positive emotional experiences such as positive affect. Examples of PP activities include recalling positive life events and performing acts of kindness. This pilot study will examine the tolerability and efficacy of a PP training program to increase positive affect in patients with multiple sclerosis (MS). In the intervention phase, subjects randomized to the intervention group will complete five weeks of PP exercises, one exercise per week. Subjects will also have weekly calls with the study trainer. The control group will have no study activities. In the extension phase, subjects in the control group will complete PP training as described above. The investigators will examine the tolerability of the program by calculating the proportion of subjects who complete the program. The investigators will also examine exercise-specific ratings of ease and utility to measure the acceptability of each exercise. Finally, the investigators will evaluate the efficacy of PP training by comparing subjects in the intervention and control groups on measures of positive affect, emotional function, health-related quality of life (HRQOL) and self-reported functional activities such as work. If successful, this study will advance the use of PP as a low cost, innovative and effective tool for increasing positive affect, decreasing depression and anxiety and improving HRQOL in patients with MS.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of multiple sclerosis according to the McDonald 2010 diagnostic criteria
  • Age 18-65
  • Ability to speak, read and write in English
  • Enrollment in the Comprehensive Longitudinal Investigation of Multiple Sclerosis at the Brigham and Women's Hospital, Partners MS Center: The CLIMB Study.

Exclusion Criteria

  • Moderate or marked cognitive abnormalities on brief mental status testing identified that would preclude meaningful participation in the PP exercises.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03637699). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search